Skip to main content
Help with accessibility
Skip to main navigation
Toggle navigation
Home
Committee
Policies and reports
APC policy
Conflicts of interest
Annual report
Free of charge medicines schemes
Controlled drugs
Out-of-area Prescribing Requests
APC fast-track process
Forms and applications
New service developments
Individual funding requests
Appeal process
Publications
Recommendations
Formulary
Online access
RAG criteria
Anti-infective therapy
NICE adherence
Guidelines
Prescribing support
Shared care
Safety
Breadcrumb
In this section
Home
Acetylcholinesterase inhibitors and memantine for the treatment of Alzheimer's Disease
Acetylcholinesterase inhibitors and memantine for the treatment of Alzheimer's Disease
CCG Approval Status:
Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added:
13
-
Mar
-
2013
Body System:
Nervous system
Purple
Acetylcholinesterase inhibitors and memantine for the treatment of Alzheimer's Disease
